Table 2 Characteristics of study population and patients with and without lithium prescription
N | Study population | Patients with Li prescription | Patients without Li prescription |
|---|---|---|---|
97,422 | 4543 | 92,879 | |
Age in years | |||
≤ 30 | 19,202 (19.7%) | 728 (16.0%) | 18,474 (19.9%) |
31–60 | 52,492 (53.9%) | 2782 (61.2%) | 49,710 (53.5%) |
> 60 | 25,728 (26.4%) | 1033 (22.7%) | 24,695 (26.6%) |
Mean | 49.2 (SD 18.9) | 48.7 (SD 15.6) | 49.2 (SD 19.1) |
Sex | |||
Male | 47,223 (48.5%) | 1975 (43.5%) | 45,248 (48.7%) |
Female | 50,114 (51.4%) | 2563 (56.4%) | 47,551 (51.2%) |
Missing | 85 (0.1%) | 5 (0.1%) | 80 (0.1%) |
Most frequent principal psychiatric diagnoses | |||
F33—22,535 (23.1%) | F33—1351 (29.7%) | F33—21,184 (22.8%) | |
F20—13,915 (14.3%) | F31—1344 (29.6%) | F20—13,579 (14.6%) | |
F32—11,073 (11.4%) | F25—697 (15.3%) | F32—10,876 (11.7%) | |
F10—10,178 (10.5%) | F20—336 (7.4%) | F10—10,122 (10.9%) | |
F05—4566 (4.7%) | F32—197 (4.3%) | F05—4551 (4.9%) | |
F25—4556 (4.7%) | F60—197 (4.3%) | F25—3859 (4.2%) | |
F31—4292 (4.4%) | F43—72 (1.6%) | F43—3720 (4.0%) | |
F43—3792 (3.9%) | F10—56 (1.2%) | F31—2948 (3.2%) | |
F60—3128 (3.2%) | F70—39 (0.9%) | F60—2931 (3.2%) | |
F06—2084 (2.1%) | F71—34 (0.7%) | F06—2055 (2.2%) | |